SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-140832
Filing Date
2023-05-10
Accepted
2023-05-10 16:56:17
Documents
16
Period of Report
2023-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d481853d8k.htm   iXBRL 8-K 30369
2 EX-1.1 d481853dex11.htm EX-1.1 19143
3 EX-5.1 d481853dex51.htm EX-5.1 8828
7 GRAPHIC g481853g0510113633905.jpg GRAPHIC 1638
8 GRAPHIC g481853g0510114437943.jpg GRAPHIC 7169
  Complete submission text file 0001193125-23-140832.txt   200850

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA beam-20230510.xsd EX-101.SCH 2835
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE beam-20230510_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE beam-20230510_pre.xml EX-101.PRE 10802
10 EXTRACTED XBRL INSTANCE DOCUMENT d481853d8k_htm.xml XML 3223
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 23907416
SIC: 2836 Biological Products, (No Diagnostic Substances)